SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-082966
Filing Date
2021-06-21
Accepted
2021-06-21 06:20:50
Documents
2
Period of Report
2021-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120087d1_8k.htm 8-K 50389
2 EXHIBIT 99.1 tm2120087d1_ex99-1.htm EX-99.1 120882
  Complete submission text file 0001104659-21-082966.txt   172594
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-38709 | Film No.: 211027230
SIC: 2834 Pharmaceutical Preparations